|We invite you to the 4th Annual Biotech Start-up Symposium, a free, two-day event to help Biotech Start-ups navigate their path to commercialization. This Symposium features industry experts who present and discuss various aspects of emerging technologies and the latest trends in their fields.
On November 15th, Day 2, you won’t want to miss the presentation by Bauke Anninga on The Current State of Emerging Biotech Venture Capital & How to Successfully Raise Funds
Here is an overview of what will be discussed:
M Ventures is the corporate venture capital arm of our company and provides investment and strategic advice to emerging biotech and life sciences companies. The financing landscape has seen a change in recent years and this presentations aims to provide an insight on the changes in the biotech VC landscape and tips from an investor’s perspective for companies that are fundraising.
Bauke is a Principal in the Biotechnology team at M Ventures. He serves on the boards of Immunitas Therapeutics, iOnctura, NanoSyrinx, and Pictor Labs. Before joining M Ventures, he was with Jefferies International in the Healthcare Investment Banking group in London (UK). During his time at Jefferies he advised on several financings and M&A transactions across the biotechnology, pharmaceutical and medical devices sectors. Bauke has a PhD in Cancer Studies from King’s College London (UK) and an MSc in Technical Medicine from the University of Twente (The Netherlands).